Increased level of tumor infiltrating CD4+ and CD8+ T cells and decreased level of myeloid-derived suppressor cells (MDSC) were observed in the tumors of the combination treatment group, compared with monotherapy (figure 1C, D). This evidence concerns the gene CD4 and neoplasm.